Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2026 07:30 ET | Source: Annovis Bio Inc.

Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study

MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
December 18, 2025 16:35 ET | Source: Annovis Bio Inc.

Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients

Annovis will begin Open-Label Extension study in Parkinson's disease patients